CO5031246A1 - Compuestos calciliticos - Google Patents

Compuestos calciliticos

Info

Publication number
CO5031246A1
CO5031246A1 CO99020604A CO99020604A CO5031246A1 CO 5031246 A1 CO5031246 A1 CO 5031246A1 CO 99020604 A CO99020604 A CO 99020604A CO 99020604 A CO99020604 A CO 99020604A CO 5031246 A1 CO5031246 A1 CO 5031246A1
Authority
CO
Colombia
Prior art keywords
riv
alkyl
group
substituted
cycloalkyl
Prior art date
Application number
CO99020604A
Other languages
English (en)
Inventor
Kumar Bhatnager Pradip
Lorraine Burgess Joelle
James Francis Callahan
Raul Rolando Calvo
Mar Eric G Del
Maria Amparo Lago
Thomas The Nguyen
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of CO5031246A1 publication Critical patent/CO5031246A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
    • C07C255/32—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring
    • C07C255/33—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring with cyano groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by saturated carbon chains
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44—Iso-indoles; Hydrogenated iso-indoles
    • C07D209/48—Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C217/04—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C217/06—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted
    • C07C217/14—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring
    • C07C217/18—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted
    • C07C217/22—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted by carbon atoms having at least two bonds to oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C217/56—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms
    • C07C217/60—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms linked by carbon chains having two carbon atoms between the amino groups and the six-membered aromatic ring or the condensed ring system containing that ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
    • C07C255/32—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring
    • C07C255/37—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring the carbon skeleton being further substituted by etherified hydroxy groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C255/54—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and etherified hydroxy groups bound to the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C255/57—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and carboxyl groups, other than cyano groups, bound to the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
    • C07C311/02—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C311/03—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atoms of the sulfonamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C311/06—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atoms of the sulfonamide groups bound to hydrogen atoms or to acyclic carbon atoms to acyclic carbon atoms of hydrocarbon radicals substituted by carboxyl groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Un compuesto de acuerdo con la fòrmula (I) siguiente:en la que : Y1 es un enlace covalente, alquileno o alquenileno de hasta 4 átomos de carbono, no sustituido o sustituido con alquilo C1-4 , u O;Y2 es metileno, no sustituido o sustituido con alquilo o haloalquilo C1-4 ;Y3 es un enlace covalente u O, S, N-RIV , o alquileno C1-4 -O, alquileno C1-4 -S, o alquileno C1-4 -N-RIV ;R3 y R4 son independientemente metilo o etilo, o forman conjuntamente ciclopropilo;R5 es arilo o arilo fusionado, dihidro- o tetrahidro-arilo fusionado, no sustituido o sustituido con cualesquier sustituyentes seleccionados del grupo que consiste en OH, halógeno alquilo C1-4 , alcoxilo C1-4 , cicloalquilo C3-6 , OSO2 RIV , CN, NO2 , OCF3 , CF3 , CH2 CF3 , (CH2 )n CO2 RIV y O-(CH2 )n CO2 RIV , en los que n es un número entero de 0 a 3 y RIV es seleccionado del grupo que consiste en H, alquilo C1-4 y cicloalquilo C3-6 ; o R5 es heteroarilo o heteroarilofusionado, en el que el heteroanillo contiene N, O o S y es aromático, dihidrogenado o tetrahidrogenado, no sustituido o sustituido con cualesquier sustituyentes seleccionados del grupo que consiste en OH, OCH3 , CH(CH3 )2 , halógeno, alquilo C1-4 , alcoxilo C1-4 , cicloalquilo C3-6, OSO2RIV , CN, NO2 , OCF3 , CF3 , CH2 CF3 , (CH2 )n CO2 H, (CH2 )n CO2 RIV y O-(CH2 )n CO2 RIV ;G es un enlace covalente CHR6 o C-R6 , en los que R6 es H, OH u O (formando una cetona);R7 es H, OH u O-alquilo C1-4 ;R8 es H o alquilo C1-4 ; o R7 y R8 forman conjuntamente una cetona;A y B son independientemente seleccionados del grupo que consiste en un enlace, CH2 , NH, O, S y C=O, con tal que A o B sea selecionado entre CH2 y NH; o A y B forman conjuntamente un enlace; o el grupo A-B es representado por CH=CH o CºC;en la que :X1 y X5 son independientemente seleccionados del grupo que consiste en H, halógeno, CN, NO2 , alquilo C1-4 , cicloalquilo, CH2 -arilo y CH2 -heteroarilo; ...
CO99020604A 1998-04-08 1999-04-08 Compuestos calciliticos CO5031246A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US8109398P 1998-04-08 1998-04-08

Publications (1)

Publication Number Publication Date
CO5031246A1 true CO5031246A1 (es) 2001-04-27

Family

ID=22162059

Family Applications (1)

Application Number Title Priority Date Filing Date
CO99020604A CO5031246A1 (es) 1998-04-08 1999-04-08 Compuestos calciliticos

Country Status (34)

Country Link
US (1) US6395919B1 (es)
EP (1) EP1070048B1 (es)
JP (1) JP2002510671A (es)
KR (1) KR20010042526A (es)
CN (1) CN1304401A (es)
AP (1) AP1271A (es)
AR (1) AR018177A1 (es)
AT (1) ATE303358T1 (es)
AU (1) AU752389B2 (es)
BG (1) BG104916A (es)
BR (1) BR9909486A (es)
CA (1) CA2327279A1 (es)
CO (1) CO5031246A1 (es)
DE (1) DE69927008T2 (es)
DZ (1) DZ2751A1 (es)
EA (1) EA200001039A1 (es)
EG (1) EG24178A (es)
ES (1) ES2247795T3 (es)
HK (1) HK1034243A1 (es)
HU (1) HUP0101346A3 (es)
ID (1) ID27004A (es)
IL (1) IL138918A0 (es)
MX (1) MXPA00009844A (es)
MY (1) MY121054A (es)
NO (1) NO20005006L (es)
NZ (1) NZ507288A (es)
OA (1) OA11499A (es)
PE (1) PE20000415A1 (es)
PL (1) PL343357A1 (es)
SK (1) SK14852000A3 (es)
TR (1) TR200002896T2 (es)
UA (1) UA58586C2 (es)
WO (1) WO1999051569A1 (es)
ZA (1) ZA200005369B (es)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ECSP003590A (es) * 1999-07-31 2002-02-25 Smithkline Beecham Corp Compuestos calcioliticos
MY159417A (en) * 2000-01-24 2017-01-13 Smithkline Beecham Corp Calcilytic compounds
US20030018203A1 (en) 2002-07-17 2003-01-23 Largo Maria Amparo Calcilytic compounds
FR2812875B1 (fr) 2000-08-08 2003-12-12 Centre Nat Rech Scient Nouvelles diamines possedant une activite modulatrice des casr et leur mode de preparation
ATE411275T1 (de) 2000-08-11 2008-10-15 Japan Tobacco Inc Calciumrezeptor-antagonisten
ES2273909T3 (es) * 2000-10-25 2007-05-16 Smithkline Beecham Corporation Compuestos calciliticos.
UY28089A1 (es) 2002-11-26 2004-06-30 Smithkline Beecham Corp Compuestos calciliticos
WO2004069793A2 (en) 2003-01-28 2004-08-19 Bristol-Myers Squibb Company Novel 2-substituted cyclic amines as calcium sensing receptor modulators
US7205322B2 (en) 2003-02-12 2007-04-17 Bristol-Myers Squibb Company Thiazolidine compounds as calcium sensing receptor modulators
AU2004232604C1 (en) * 2003-04-23 2008-06-05 Japan Tobacco Inc. CaSR antagonists
WO2004106280A1 (ja) 2003-05-28 2004-12-09 Japan Tobacco Inc. ＣａＳＲアンタゴニスト
US7265145B2 (en) 2003-05-28 2007-09-04 Bristol-Myers Squibb Company Substituted piperidines and pyrrolidines as calcium sensing receptor modulators and method
US20070155819A1 (en) * 2004-02-06 2007-07-05 Marquis Robert W Jr Calcilytic compounds
US7648965B2 (en) * 2004-05-14 2010-01-19 Unigene Laboratories Inc. Method for fostering bone formation and preservation
US7531518B2 (en) * 2004-05-14 2009-05-12 Unigene Laboratories Inc. Method for fostering bone formation and preservation
US20060293667A1 (en) * 2005-05-19 2006-12-28 Agnes Vignery Bone implant device and methods of using same
WO2007027548A2 (en) 2005-09-02 2007-03-08 Amgen Inc. Methods of modulating intestinal fluid balance
EP2139462B1 (en) * 2007-03-30 2014-01-22 Amgen Inc. Calcimimetic compounds for use in the treatment of bowel disorders
ES2412408T3 (es) * 2008-12-24 2013-07-11 Daiichi Sankyo Company, Limited Compuestos de indanilo
WO2010103429A1 (en) 2009-03-10 2010-09-16 Pfizer Inc. 1,1-(Dimethyl-Ethylamino)-2-Hydroxy-Propoxy]-Ethyl}-3-Methyl-Biphenyl-4- Carboxylic Acid Derivatives As Calcium Receptor Antagonists
GB201217330D0 (en) 2012-09-28 2012-11-14 Univ Cardiff Therapeutic for treating inflammatory lung disorders

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2533210A1 (fr) * 1982-09-17 1984-03-23 Lyon I Universite Claude Edulcorants de synthese
DE3301198A1 (de) * 1983-01-15 1984-07-19 Hoechst Ag, 6230 Frankfurt N-arylalkylamin-3-propoxypyridin-derivate, verfahren zu ihrer herstellung, sie enthaltende pharmazeutische praeparate und deren verwendung
US5541204A (en) * 1994-12-02 1996-07-30 Bristol-Myers Squibb Company Aryloxypropanolamine β 3 adrenergic agonists
CN1202106A (zh) * 1995-09-21 1998-12-16 伊莱利利公司 选择性的β3肾上腺素能激动剂
SG99290A1 (en) 1996-04-09 2003-10-27 Nps Pharma Inc Calcilytic compounds

Also Published As

Publication number Publication date
MXPA00009844A (es) 2003-07-14
CA2327279A1 (en) 1999-10-14
NZ507288A (en) 2003-05-30
NO20005006D0 (no) 2000-10-04
HK1034243A1 (en) 2001-10-19
AR018177A1 (es) 2001-10-31
US6395919B1 (en) 2002-05-28
BG104916A (en) 2001-06-29
ID27004A (id) 2001-02-22
EP1070048A4 (en) 2001-11-07
AP2000001931A0 (en) 2000-09-30
PL343357A1 (en) 2001-08-13
ES2247795T3 (es) 2006-03-01
NO20005006L (no) 2000-10-04
EP1070048A1 (en) 2001-01-24
IL138918A0 (en) 2001-11-25
ATE303358T1 (de) 2005-09-15
PE20000415A1 (es) 2000-05-21
UA58586C2 (uk) 2003-08-15
AU3481999A (en) 1999-10-25
TR200002896T2 (tr) 2001-01-22
KR20010042526A (ko) 2001-05-25
EG24178A (en) 2008-09-28
HUP0101346A2 (hu) 2001-08-28
ZA200005369B (en) 2001-12-18
WO1999051569A1 (en) 1999-10-14
EA200001039A1 (ru) 2001-04-23
JP2002510671A (ja) 2002-04-09
AU752389B2 (en) 2002-09-19
OA11499A (en) 2004-05-05
AP1271A (en) 2004-04-21
DE69927008T2 (de) 2006-03-16
SK14852000A3 (sk) 2001-05-10
DZ2751A1 (fr) 2003-09-15
BR9909486A (pt) 2001-11-06
MY121054A (en) 2005-12-30
DE69927008D1 (de) 2005-10-06
CN1304401A (zh) 2001-07-18
HUP0101346A3 (en) 2003-03-28
EP1070048B1 (en) 2005-08-31

Similar Documents

Publication Publication Date Title
CO5031246A1 (es) Compuestos calciliticos
CO4950536A1 (es) Compuestos calciliticos
CY1106858T1 (el) Νεα παραγωγα κυκλικου αμιδιου
AR012032A1 (es) Compuestos derivados 3'-n-oxido, 3'-n-dimetilamina, 9-oxima eritromicina a y un proceso para su preparacion
TR200401413T1 (tr) Dibenzilamin bileşikleri ve bunların farmasötik kullanımları
UA76409C2 (uk) Трифенілалкенові похідні і їх застосування як селективних модуляторів рецепторів естрогену
BR0213140A (pt) Fungicidas de pirazol-pirimidina
CO5021223A1 (es) Compuestos calciliticos calciliticos
CO5590897A2 (es) Compuestos heterociclicos que proporcionan agentes farmacologicos que son potentes agonistas de ppars y composiciones farmaceuticas que los contienen
CR6805A (es) Derivados novedosos de eter de propargil-fenil
CY1108398T1 (el) Διαδικασια και ενδιαμεσα για την παραγωγη 7-υποκατεστημενων αντιοιστρογονων
HRP20050390A2 (en) Substituted benzoxazinones and uses thereof
AR052915A1 (es) Derivados de pirrolidin y piperidin acetileno
CO5690598A2 (es) 6-[(sustituido)fenil]triazolopirimidinas como agentes anticancer
CO5631434A2 (es) Derivados de piridina-carboxamida y su uso como plaguicidas
AR045868A1 (es) Proceso para preparar compuestos de ocarbamoilo en presencia de grupo amina activa
NO20004295D0 (no) Nye pyridinforbindelser, fremgangsmÕte ved deres fremstilling og farmasøytiske sammensetninger inneholdende dem
SE7602122L (sv) Nya piperazinyliminorifamyciner och sett att framstella desamma
DE60229054D1 (de) Synthese von zyklopentadien derivaten
ES2321307T8 (es) Uso de derivados de 4-ciano-naftaleno-1,8-dicarboximida y compuestos relacionados para proteger material orgánico de los efectos dañinos de la luz.
MXPA02012569A (es) Ftalidas substituidas novedosas, un procedimiento para su preparacion y las composiciones farmaceuticas que contienen a las mismas.
MX9301045A (es) Procedimiento para preparar antagonistas receptores de fibrinogeno.
CL2004000160A1 (es) Derivados de avermectina sustituidos en posicion 4' y 4'', composicion que los contiene, utiles como plaguicidas.
EA200200611A1 (ru) Новые тетрагидропиридины, способ их получения и содержащие их фармацевтические композиции
EA200400323A1 (ru) Аралкилтетрагидропиридины, их получение и содержащие их фармацевтические композиции